Background: Asthma, a chronic lung disease, is a significant public health problem worldwide. It is marked by increased T2 response resulting in eosinophil accumulation. The pathophysiology of asthma involves various cell types, including epithelial cells, dendritic cells (DCs), innate lymphoid cells, B cells, and effector cells.
View Article and Find Full Text PDFThe aryl hydrocarbon receptor (AhR) is a decisive regulatory ligand-dependent transcription factor. It binds highly diverse ligands, which can be categorized as either endogenous or exogenous. Ligand binding activates AhR, which can adjust inflammatory responses by modulating immune cells such as dendritic cells (DCs).
View Article and Find Full Text PDFChronic inflammatory diseases and transplant rejection represent major challenges for modern health care. Thus, identification of immune checkpoints that contribute to resolution of inflammation is key to developing novel therapeutic agents for those conditions. In recent years, the CD83 (cluster of differentiation 83) protein has emerged as an interesting potential candidate for such a "pro-resolution" therapy.
View Article and Find Full Text PDFLeishmaniasis is a complex vector-borne disease mediated by Leishmania parasite and a strong and long-lasting CD4 Th1 and CD8-T cell immunity is required to control the infection. Thus far multivalent subunit vaccines have met this requirement more promisingly. However several full protein sequences cannot be easily arranged in one construct.
View Article and Find Full Text PDFTuberculosis has been declared as a global emergency. Latent tuberculosis infection (LTBI) is a state in which host immunity cannot completely eradicate . Cigarette smoke increases the risk of respiratory infections, such a TB, as it has adverse effects on respiratory immune function.
View Article and Find Full Text PDF